JP2023518245A5 - - Google Patents
Info
- Publication number
- JP2023518245A5 JP2023518245A5 JP2022555945A JP2022555945A JP2023518245A5 JP 2023518245 A5 JP2023518245 A5 JP 2023518245A5 JP 2022555945 A JP2022555945 A JP 2022555945A JP 2022555945 A JP2022555945 A JP 2022555945A JP 2023518245 A5 JP2023518245 A5 JP 2023518245A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025225446A JP2026035788A (ja) | 2020-03-18 | 2025-12-03 | ソフトゲルカプセル |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062991354P | 2020-03-18 | 2020-03-18 | |
| US62/991,354 | 2020-03-18 | ||
| PCT/US2021/022918 WO2021188773A1 (en) | 2020-03-18 | 2021-03-18 | Softgel capsules |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025225446A Division JP2026035788A (ja) | 2020-03-18 | 2025-12-03 | ソフトゲルカプセル |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023518245A JP2023518245A (ja) | 2023-04-28 |
| JPWO2021188773A5 JPWO2021188773A5 (https=) | 2024-03-21 |
| JP2023518245A5 true JP2023518245A5 (https=) | 2024-03-21 |
| JP7785682B2 JP7785682B2 (ja) | 2025-12-15 |
Family
ID=77771391
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022555945A Active JP7785682B2 (ja) | 2020-03-18 | 2021-03-18 | ソフトゲルカプセル |
| JP2025225446A Pending JP2026035788A (ja) | 2020-03-18 | 2025-12-03 | ソフトゲルカプセル |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025225446A Pending JP2026035788A (ja) | 2020-03-18 | 2025-12-03 | ソフトゲルカプセル |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230172864A1 (https=) |
| EP (1) | EP4121036A4 (https=) |
| JP (2) | JP7785682B2 (https=) |
| KR (1) | KR20220154196A (https=) |
| AR (1) | AR121608A1 (https=) |
| AU (1) | AU2021238345A1 (https=) |
| BR (1) | BR112022018268A2 (https=) |
| CA (1) | CA3171512A1 (https=) |
| CO (1) | CO2022014130A2 (https=) |
| MX (1) | MX2022011549A (https=) |
| WO (1) | WO2021188773A1 (https=) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030133939A1 (en) * | 2001-01-17 | 2003-07-17 | Genecraft, Inc. | Binding domain-immunoglobulin fusion proteins |
| EP1545477A4 (en) * | 2002-09-13 | 2006-11-22 | Cydex Inc | CAPSULES CONTAINING AQUEOUS FILLING COMPOSITIONS STABILIZED WITH DERIVED CYCLODEXTRIN |
| ITMI20022777A1 (it) * | 2002-12-27 | 2004-06-28 | Altergon Sa | Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento. |
| EP2444071A1 (en) * | 2004-09-27 | 2012-04-25 | Sigmoid Pharma Limited | Minicapsule formulations |
| CN1872061A (zh) * | 2006-04-17 | 2006-12-06 | 宛六一 | 一种药物组合物软胶囊及其制备方法 |
| JP5840668B2 (ja) * | 2012-12-07 | 2016-01-06 | 富士カプセル株式会社 | ロキソプロフェンナトリウム含有軟カプセル用内容物、及び、それを含有する軟カプセル製剤 |
| US10420729B2 (en) * | 2013-03-15 | 2019-09-24 | R.P. Scherer Technologies, Llc | Abuse resistant capsule |
| US9326947B1 (en) * | 2014-02-28 | 2016-05-03 | Banner Life Sciences Llc | Controlled release fumarate esters |
| US9775814B2 (en) * | 2014-06-20 | 2017-10-03 | Patheon Softgels Inc. | Enteric soft capsule compositions |
| US20150366814A1 (en) * | 2014-06-23 | 2015-12-24 | Banner Life Sciences Llc | All-natural enteric soft capsules comprising active ingredients |
| ES2787220T3 (es) * | 2015-03-26 | 2020-10-15 | Patheon Softgels Inc | Cápsulas blandas llenas de líquido |
| US20180049999A1 (en) * | 2015-04-14 | 2018-02-22 | Atossa Genetics Inc. | Compositions and methods of treatment of breast disorders and estrogen-related disorders |
| US20170119680A1 (en) * | 2015-10-30 | 2017-05-04 | R.P. Scherer Technologies, Llc | Extended release film-coated capsules |
| IL316439A (en) * | 2018-03-15 | 2024-12-01 | Scherer Technologies Llc R P | Enteric softgel capsules |
| IT201800003615A1 (it) * | 2018-03-15 | 2019-09-15 | Altergon Sa | Formulazioni altamente stabili di ormone tiroideo in capsule molli |
-
2021
- 2021-03-18 JP JP2022555945A patent/JP7785682B2/ja active Active
- 2021-03-18 MX MX2022011549A patent/MX2022011549A/es unknown
- 2021-03-18 AR ARP210100679A patent/AR121608A1/es unknown
- 2021-03-18 CA CA3171512A patent/CA3171512A1/en active Pending
- 2021-03-18 US US17/910,999 patent/US20230172864A1/en active Pending
- 2021-03-18 AU AU2021238345A patent/AU2021238345A1/en active Pending
- 2021-03-18 WO PCT/US2021/022918 patent/WO2021188773A1/en not_active Ceased
- 2021-03-18 EP EP21771183.7A patent/EP4121036A4/en active Pending
- 2021-03-18 KR KR1020227035608A patent/KR20220154196A/ko active Pending
- 2021-03-18 BR BR112022018268A patent/BR112022018268A2/pt unknown
-
2022
- 2022-09-30 CO CONC2022/0014130A patent/CO2022014130A2/es unknown
-
2025
- 2025-12-03 JP JP2025225446A patent/JP2026035788A/ja active Pending